HEIDI LINDSTAD: Open Payments
NPI 1952890808 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 14 payments from 7 companies in 2025. Trend: 2023 $279 · 2024 $1,571 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 7 | $142 |
| Amgen Inc. | 1 | $90 |
| ABBVIE INC. | 2 | $28 |
| PFIZER INC. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Celgene Corporation | 1 | $18 |
Products named: TYSABRI, UPLIZNA, VUMERITY, NURTEC ODT, AUSTEDO XR, CREXONT, ZEPOSIA, UBRELVY.
Industry payments across IA — which companies pay providers there.
